tm
Seeing Is Believing
tm
Seeing Is Believing
CLDI is currently covered by 1 analysts with an average price target of $1.28. This is a potential upside of $-0.34 (-20.99%) from yesterday's end of day stock price of $1.62.
Calidi Biotherapeutics's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of CLDI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 15 days.
Highest price target for CLDI is $30, Lowest price target is $2, average price target is $2.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 15-May-2024. First documented stock forecast 09-Oct-2023.
Currently out of the existing stock ratings of CLDI, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2
$0.4 (25.00%)
$4.5
1 years 3 months 28 days ago
(15-May-2024)
2/2 (100%)
$-0.34 (-14.53%)
15
What is CLDI (Calidi Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CLDI (Calidi Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on CLDI (Calidi Biotherapeutics)?
Which analyst is the currently most bullish on CLDI (Calidi Biotherapeutics)?
